Liver Cancer Cell Lines
Database

LCCL to predict drug response

Drug: Regorafenib

DrugsAliasTargetsTargeted cellular functionClinical status in any tumor typeClinical status in HCCSupplierReference
Regorafenib BAY 73-4506 VEGFR1/2/3, PDGFRB, KIT, RET, RAF1 Tyrosine kinases Approved Approved Selleck Chemicals S1178

Cell Line (34)
Cell LineAUCGI50
Li70.883.9
Huh70.916.0
HCC.1.20.9710.0
SNU3540.9710.0
JHH50.9810.0
SNU1820.9910.0
Hep3B0.9910.0
HepG21.010.0
HLF1.010.0
SNU7391.010.0
JHH61.010.0
JHH71.010.0
SNU3871.0110.0
SNU8861.0110.0
SNU3981.0210.0


LCCL transcriptomic subgroup:
CL1
CL2
CL3
undef.

Codebase Soc. Coop.
info@codebase.it